Delaware counts the cost of a Pfizer takeover of AstraZeneca

The state of Delaware is worried that it would lose AstraZeneca's ($AZN) U.S. headquarters--and the thousands of jobs that go with it--should Pfizer ($PFE) succeed in buying the U.K. company. Report